AU3774500A - Nucleic acids including open reading frames encoding polypeptides; "orfx" - Google Patents

Nucleic acids including open reading frames encoding polypeptides; "orfx"

Info

Publication number
AU3774500A
AU3774500A AU37745/00A AU3774500A AU3774500A AU 3774500 A AU3774500 A AU 3774500A AU 37745/00 A AU37745/00 A AU 37745/00A AU 3774500 A AU3774500 A AU 3774500A AU 3774500 A AU3774500 A AU 3774500A
Authority
AU
Australia
Prior art keywords
orfx
nucleic acids
open reading
reading frames
acids including
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37745/00A
Inventor
Martin Leach
Richard A. Shimkets
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CuraGen Corp filed Critical CuraGen Corp
Publication of AU3774500A publication Critical patent/AU3774500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
AU37745/00A 1999-03-31 2000-03-31 Nucleic acids including open reading frames encoding polypeptides; "orfx" Abandoned AU3774500A (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US12760799P 1999-03-31 1999-03-31
US60127607 1999-03-31
US12763699P 1999-04-02 1999-04-02
US60127636 1999-04-02
US12772899P 1999-04-05 1999-04-05
US60127728 1999-04-05
US54076300A 2000-03-30 2000-03-30
US09540763 2000-03-30
PCT/US2000/008621 WO2000058473A2 (en) 1999-03-31 2000-03-31 Nucleic acids including open reading frames encoding polypeptides; 'orfx'

Publications (1)

Publication Number Publication Date
AU3774500A true AU3774500A (en) 2000-10-16

Family

ID=27494693

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37745/00A Abandoned AU3774500A (en) 1999-03-31 2000-03-31 Nucleic acids including open reading frames encoding polypeptides; "orfx"

Country Status (5)

Country Link
EP (1) EP1165784A2 (en)
JP (1) JP2004507202A (en)
AU (1) AU3774500A (en)
CA (1) CA2383592A1 (en)
WO (1) WO2000058473A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001262734B2 (en) * 2000-06-14 2004-09-30 Sankyo Company, Limited Ceramide kinase and DNA encoding the same
AU783485B2 (en) * 1999-11-10 2005-11-03 Lexicon Pharmaceuticals, Inc. Human atpase proteins and polynucleotides encoding the same
AU784349B2 (en) * 2000-01-12 2006-03-16 Yale University Nogo receptor-mediated blockade of axonal growth
AU2001249421B2 (en) * 2000-03-24 2006-09-07 Genetics Institute, Llc A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor

Families Citing this family (256)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034626A1 (en) * 1999-11-05 2001-05-17 Human Genome Sciences, Inc. 28 human secreted proteins
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6372473B1 (en) * 1997-05-28 2002-04-16 Human Genome Sciences, Inc. Tissue plasminogen activator-like protease
US6528640B1 (en) * 1997-11-05 2003-03-04 Ribozyme Pharmaceuticals, Incorporated Synthetic ribonucleic acids with RNAse activity
US6482932B1 (en) * 1997-11-05 2002-11-19 Ribozyme Pharmaceuticals, Incorporated Nucleoside triphosphates and their incorporation into oligonucleotides
US6617438B1 (en) * 1997-11-05 2003-09-09 Sirna Therapeutics, Inc. Oligoribonucleotides with enzymatic activity
US6300096B1 (en) 1998-01-15 2001-10-09 Whitehead Institute For Biomedical Research Polynucleotides encoding fatty acid transport proteins
US7033772B1 (en) 1998-01-15 2006-04-25 Millennium Pharmaceuticals, Inc. Methods of identifying inhibitors of fatty acid transport proteins (FATP)
US6265192B1 (en) 1998-03-20 2001-07-24 The Regents Of The University Of California Glycosly sulfortransferase-3
US6365365B1 (en) 1998-03-20 2002-04-02 The Regents Of The University Of California Method of determining whether an agent modulates glycosyl sulfotransferase-3
US7241862B2 (en) 1998-05-15 2007-07-10 Genentech, Inc. Polypeptides that induce cell proliferation or induce fetal hemoglobin
WO2001062926A2 (en) * 2000-02-25 2001-08-30 Millennium Pharmaceuticals, Inc. 44576, a novel g-protein coupled receptor and uses therefor
WO2001066756A2 (en) * 2000-03-07 2001-09-13 Millenium Pharmaceuticals, Inc. 22105, a human thioredoxin family member and uses thereof
EP1593687A3 (en) * 1998-06-10 2006-10-18 Bayer Corporation Human genes differentially expressed in colon cancer
US20030003507A1 (en) 1999-06-02 2003-01-02 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US7258973B2 (en) * 1998-08-31 2007-08-21 Mayo Foundation For Medical Education & Research Method for detecting a differentially expressed sequence
US6730491B2 (en) 2000-02-29 2004-05-04 Millennium Pharmaceuticals, Inc. 2504, 15977, and 14760, novel protein kinase family members and uses therefor
US20030096391A1 (en) * 2000-12-22 2003-05-22 Millennium Pharmaceuticals, Inc. 17903, a novel human aminopeptidase and uses therefor
JP4315301B2 (en) * 1998-10-30 2009-08-19 独立行政法人科学技術振興機構 Human H37 protein and cDNA encoding this protein
US7867731B2 (en) 1998-11-04 2011-01-11 Novartis Vaccines And Diagnostics, Inc. HX2004-6 polypeptide expressed in cancerous cells
US6743602B1 (en) 1999-07-26 2004-06-01 Chiron Corporation Polynucleotides differentially expressed in adenocarcinomas, polypeptides encoded thereby, and methods of use thereof
AU2396700A (en) * 1998-12-30 2000-07-31 Millennium Pharmaceuticals, Inc. Secreted proteins and uses thereof
ES2259058T3 (en) * 1999-02-12 2006-09-16 Genentech, Inc. AMPLIFIED GENE IN TUMORS, AND RELATED MATERIALS AND PROCEDURES.
DK1632499T3 (en) * 1999-03-08 2007-10-01 Genentech Inc Gene sequences amplified in tumors and diagnostic applications thereof
DE60039677D1 (en) * 1999-03-19 2008-09-11 Aventis Pharma Inc AKT-3 NUCLEIC ACID, POLYPEPTIDES, AND ITS USE
US6881555B2 (en) 1999-03-19 2005-04-19 Aventis Pharmaceuticals Inc. AKT nucleic acids, polypeptides, and uses thereof
ATE449108T1 (en) * 1999-03-23 2009-12-15 Genentech Inc SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACID CODING THEREFOR
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
JP2003501038A (en) * 1999-05-28 2003-01-14 スージェン・インコーポレーテッド Protein kinase
AU5309500A (en) * 1999-06-07 2000-12-28 Lexicon Genetics Incorporated Novel human genes and proteins encoded thereby
WO2000078953A2 (en) * 1999-06-17 2000-12-28 Incyte Genomics, Inc. Human transport proteins
DE19928021A1 (en) * 1999-06-18 2000-12-21 Basf Ag New nucleic acid encoding testis-specific calpain-11, useful for identifying specific inhibitors for treatment of fertility disorders
WO2001002586A1 (en) * 1999-06-29 2001-01-11 Mcgill University Human alpha 1,2-mannosidase
JP2003526337A (en) * 1999-07-23 2003-09-09 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド 29 human secreted proteins
AU6374100A (en) * 1999-07-26 2001-02-13 Chiron Corporation Polynucleotides differentially expressed in adenocarcinomas, polypeptides encoded thereby, and methods of use thereof
DE19936563A1 (en) * 1999-08-04 2001-02-08 Boehringer Ingelheim Int Tumor Associated Antigen
KR100543857B1 (en) * 1999-09-01 2006-01-23 제넨테크, 인크. Promotion or Inhibition of Angiogenesis and Cardiovascularization
US6818750B2 (en) * 1999-09-01 2004-11-16 The Burnham Institute Card proteins involved in cell death regulation
AU7101700A (en) 1999-09-02 2001-03-26 Lexicon Genetics Incorporated Human calcium dependent proteases and polynucleotides encoding the same
EP1127118A1 (en) * 1999-09-02 2001-08-29 Smithkline Beecham Plc Human gs protein regulator gene
US20020049312A1 (en) * 2000-05-23 2002-04-25 Turner C. Alexander Noel human thrombospondin-like proteins and polynucleotides encoding the same
US7329529B2 (en) 1999-09-03 2008-02-12 Millennium Pharmaceuticals, Inc. Ubiqutin proteases
US20020045212A1 (en) * 2000-02-29 2002-04-18 Glucksmann Maria Alexandra Novel human GTPase activator proteins
US6329171B1 (en) 1999-09-30 2001-12-11 Millennium Pharmaceuticals, Inc. 23484, A novel human ubiquitin protease
AU6974900A (en) * 1999-09-07 2001-04-10 University Health Network A p53-induced protein with a death domain that can promote apoptosis
JP2003527092A (en) * 1999-09-15 2003-09-16 インサイト・ゲノミックス・インコーポレイテッド Proteins involved in cell differentiation
CA2385234A1 (en) * 1999-09-16 2001-03-22 Mcgill University Nrage nucleic acids and polypeptides and uses thereof
US7029895B2 (en) 1999-09-27 2006-04-18 Millennium Pharmaceuticals, Inc. 27411, a novel human PGP synthase
US6451994B1 (en) 1999-09-27 2002-09-17 Millennium Pharmaceuticals, Inc. 23413, a novel human ubiquitin protease
GB9924060D0 (en) * 1999-10-11 1999-12-15 Chiron Spa VIP54 protein
US20020081625A1 (en) * 1999-10-14 2002-06-27 John Ford Member of the immunoglobulin superfamily and uses thereof
US6420155B1 (en) * 1999-10-14 2002-07-16 Curagen Corporation Aortic carboxypeptidase-like protein and nucleic acids encoding same
WO2001029213A1 (en) * 1999-10-19 2001-04-26 The Wellcome Trust Limited As Trustee To The Wellcome Trust Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof
US20020081679A1 (en) * 1999-10-22 2002-06-27 Millennium Pharmaceuticals, Inc. NARC8 programmed cell-death-associated molecules and uses thereof
EP1234042A1 (en) * 1999-10-25 2002-08-28 Millennium Pharmaceuticals, Inc. Protein 27875, a human adam-ts homolog
AU1855001A (en) * 1999-11-15 2001-05-30 Pharmacia & Upjohn S.P.A. A new member of the pak protein family, nucleic acids and methods related to thesame
JP2003533174A (en) * 1999-11-17 2003-11-11 キュラジェン コーポレイション Novel polypeptide and nucleic acid encoding this polypeptide
US20030109428A1 (en) 1999-12-01 2003-06-12 John Bertin Novel molecules of the card-related protein family and uses thereof
CA2490853A1 (en) * 1999-12-01 2001-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001040468A2 (en) * 1999-12-01 2001-06-07 Millennium Pharmaceuticals, Inc. Molecules of the card-related protein family and uses thereof
AU2084601A (en) * 1999-12-10 2001-06-18 Biogen, Inc. Novel polypeptides and polynucleotides encoding same
US7115558B2 (en) * 1999-12-16 2006-10-03 Cytochroma Inc. P450RAI-2(P450 Cytochrome 26B), encoding nucleic acid molecules and methods and uses thereof
AU1686701A (en) * 1999-12-21 2001-07-03 University Of Zurich Dispatched polypeptides
JP2003517838A (en) * 1999-12-23 2003-06-03 インサイト・ゲノミックス・インコーポレイテッド Human kinase
US7119165B2 (en) 2000-01-12 2006-10-10 Yale University Nogo receptor-mediated blockade of axonal growth
WO2001057060A1 (en) * 2000-02-01 2001-08-09 Human Genome Sciences, Inc. Bcl-2-like polynucleotides, polypeptides, and antibodies
AU2001230560A1 (en) * 2000-02-01 2001-08-14 Taisho Pharmaceutical Co. Ltd. Novel gene tig104alpha and protein tig104alpha encoded thereby
US7335749B2 (en) 2000-02-09 2008-02-26 The United States Of America As Represented By The Department Of Health And Human Services Tumor suppressor gene, p47Ing3
US7078205B2 (en) 2000-02-17 2006-07-18 Millennium Pharmaceuticals, Inc. Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, atpase molecules, acyltransferase molecules, pyridoxal-phosphate dependent enzyme molecules and uses therefor
DE10007468A1 (en) * 2000-02-18 2001-08-23 Basf Lynx Bioscience Ag New central nervous protein that modulates K · + · currents
SE0100472L (en) * 2000-02-18 2001-08-19 Hoffmann La Roche New metalloproteases having thrombospondome domains and nucleic acid compositions encoding these
GB0004196D0 (en) * 2000-02-19 2000-04-12 Smithkline Beecham Plc Novel compounds
US20040033509A1 (en) 2000-07-18 2004-02-19 Millennium Pharmaceuticals, Inc. Novel 13237, 18480, 2245, 16228, 7677, 26320, 46619, 33166, 16836, 46867, 21617, 55562, 39228, 62088, 46745, 23155, 21657, 42755, 32229, 22325, 46863 and 32252 molecules and uses therefor
US6864078B2 (en) * 2000-02-29 2005-03-08 Millennium Pharmaceuticals, Inc. 14790, novel protein kinase molecule and uses therefor
AU2001241928A1 (en) * 2000-02-29 2001-09-12 Millennium Pharmaceuticals, Inc. Transferase 32253 and use therefor
AU6802801A (en) * 2000-03-01 2001-09-24 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1262487A4 (en) * 2000-03-02 2004-12-22 Chugai Pharmaceutical Co Ltd Dna encoding squalene epoxidase promoter
WO2001064703A1 (en) * 2000-03-02 2001-09-07 Human Genome Sciences, Inc. Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies
US20020009777A1 (en) * 2000-03-24 2002-01-24 Meyers Rachel A. 25552, a novel human methyltransferase family member and uses thereof
WO2001090322A2 (en) * 2000-05-19 2001-11-29 Millennium Pharmaceuticals, Inc. 32244, a novel human amp-binding enzyme and uses thereof
US7301016B2 (en) 2000-03-07 2007-11-27 Millennium Pharmaceuticals, Inc. Human transferase family members and uses thereof
US20020055159A1 (en) * 2000-06-15 2002-05-09 Meyers Rachel A. 23680,a novel human aminotransferase and uses therefor
EP1263955A2 (en) * 2000-03-10 2002-12-11 Curagen Corporation Polypeptides and nucleic acids encoding same
EP1757618A3 (en) * 2000-03-22 2007-05-23 Curagen Corporation Angiogenesis-associated proteins, and nucleic acids encoding the same
EP1266007A1 (en) * 2000-03-24 2002-12-18 MERCK PATENT GmbH Human survivin interacting protein 1 (sip-1)
JP2001335598A (en) * 2000-03-24 2001-12-04 Takeda Chem Ind Ltd New protein, method for producing the same and use thereof
WO2001073043A2 (en) * 2000-03-24 2001-10-04 Millennium Pharmaceuticals, Inc. 32451, a human ubiquitin conjugating enzyme-like molecule and uses thereof
FR2806739B1 (en) * 2000-03-27 2005-02-18 Fond Jean Dausset Ceph GENES INVOLVED IN INFLAMMATORY BOWEL DISEASES AND THEIR USE
EP1138768A3 (en) * 2000-03-27 2002-08-07 Leadd B.V. Apoptin-associating protein AAP-5
EP1138765A1 (en) * 2000-03-27 2001-10-04 Leadd B.V. Apoptin-associating proteins AAP-5 and AAP-6
WO2001073022A1 (en) * 2000-03-29 2001-10-04 Kyowa Hakko Kogyo Co., Ltd. Proliferative glomerular nephritis-associated gene
US20030198953A1 (en) * 2000-03-30 2003-10-23 Spytek Kimberly A. Novel proteins and nucleic acids encoding same
EP1294899B3 (en) * 2000-03-31 2011-07-06 Millennium Pharmaceuticals, Inc. 16836, a human phospholipase c family member and uses thereof
AU5056501A (en) * 2000-03-31 2001-10-08 Nobuyuki Itoh Fibroblast growth factor-like molecules and uses thereof
US7250279B2 (en) 2000-04-07 2007-07-31 Merck Patent Gmbh Human pyruvate dehydrogenese phosphatase
WO2001079272A2 (en) * 2000-04-18 2001-10-25 Tularik Inc. Sitosterolemia susceptibility gene (ssg): compositions and methods of use
CA2407081A1 (en) * 2000-04-26 2001-11-01 Pe Corporation (Ny) Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
US20020019348A1 (en) * 2000-08-02 2002-02-14 Applera Corporation Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
EP1278843A2 (en) * 2000-04-28 2003-01-29 Incyte Genomics, Inc. Rna metabolism proteins
US6808876B1 (en) 2000-05-02 2004-10-26 Immusol, Inc. Cellular regulators of infectious agents and methods of use
US20030096312A1 (en) * 2000-05-02 2003-05-22 Claudia Wilm Novel natrium-calcium exchanger protein
US7034135B2 (en) 2000-05-03 2006-04-25 Millennium Pharmaceuticals, Inc. Molecules of the NBS/LRR protein family and uses thereof
WO2001083753A2 (en) * 2000-05-03 2001-11-08 Millennium Pharmaceuticals, Inc. Molecules of the nbs/lrr protein family and uses thereof
US20030050441A1 (en) * 2000-09-25 2003-03-13 Millennium Pharmaceuticals, Inc. 49938, a novel human phospholipid transporter and uses therefor
US20030096313A1 (en) * 2000-05-12 2003-05-22 Burkhard Scharm Novel serine-threonine kinase-4
WO2001088135A2 (en) * 2000-05-15 2001-11-22 Curagen Corporation G-protein coupled receptor proteins and nucleic acids encoding same
WO2001092524A2 (en) * 2000-05-26 2001-12-06 Aeomica, Inc. Myosin-like gene expressed in human heart and muscle
EP1158049A1 (en) * 2000-05-26 2001-11-28 Aeomica, INC. Myosin-like gene expressed in human heart and muscle
GB2380197A (en) * 2000-05-26 2003-04-02 Aeomica Inc Myosin-like gene expressed in human heart and muscle
EP1666594A3 (en) * 2000-06-02 2006-06-21 Genentech, Inc. Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer
WO2001096561A1 (en) * 2000-06-16 2001-12-20 Merck Patent Gmbh Hunc-2, human member of unc-protein family
EP1176200A3 (en) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases or wound healing and their use in indentifying pharmacologically acitve substances
CN1281749C (en) * 2000-06-26 2006-10-25 味之素株式会社 Polypeptides, use thereof and process for producing the same
CA2412256A1 (en) * 2000-06-27 2002-01-03 Curagen Corporation Polynucleotides and polypeptides encoded thereby
US20020039773A1 (en) * 2000-07-13 2002-04-04 Rosana Kapeller-Libermann 47885, a novel human ubiquitin-activating enzyme and uses therefor
EP1174502A1 (en) * 2000-07-18 2002-01-23 Schering Corporation Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
WO2002006318A2 (en) * 2000-07-18 2002-01-24 Board Of Regents, The University Of Texas System Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells
EP1307557A2 (en) * 2000-08-02 2003-05-07 The Johns Hopkins University Endothelial cell expression patterns
EP1309690B1 (en) * 2000-08-18 2006-06-07 MERCK PATENT GmbH Mfq-111, a human gtpase like protein
JP2004507242A (en) * 2000-08-24 2004-03-11 インサイト・ゲノミックス・インコーポレイテッド Kidney specific protein
AU2001293778A1 (en) * 2000-08-28 2002-03-13 Lion Bioscience Ag Novel cofactors of the pregnane x receptor and methods of use
US7166428B2 (en) 2000-08-31 2007-01-23 Millennium Pharmaceuticals, Inc. 62112, a novel human dehydrogenase and uses thereof
WO2002024739A2 (en) * 2000-09-21 2002-03-28 The Regents Of The University Of California Spas-1 cancer antigen
CA2423108A1 (en) * 2000-09-22 2003-03-19 Kyowa Hakko Kogyo Co., Ltd. .beta.-catenin nuclear localizing protein
WO2002026955A2 (en) * 2000-09-29 2002-04-04 Lexicon Genetics Incorporated Human proteases and polynucleotides encoding the same
WO2002026982A2 (en) * 2000-09-29 2002-04-04 Incyte Genomics, Inc. Secreted human proteins
US20020150916A1 (en) * 2000-10-05 2002-10-17 Rachel Meyers 43716, a novel human G-protein and uses thereof
DK1325130T3 (en) 2000-10-06 2010-05-25 Univ Yale Nogo Receptor Homologs
JP2004528812A (en) * 2000-10-12 2004-09-24 フェリング ベスローテン フェンノートシャップ Novel serine protease gene associated with DPPIV
AU2002221676A1 (en) * 2000-10-16 2002-04-29 Bayer Aktiengesellschaft Regulation of human acyl-coa dehydrogenase
US20020119518A1 (en) * 2000-10-17 2002-08-29 Merkulov Gennady V. Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2001295778A1 (en) * 2000-10-20 2002-04-29 Inpharmatica Limited Novel cysteine proteases and uses thereof
FR2822165B1 (en) * 2000-10-24 2004-12-24 Aventis Pharma Sa NUCLEIC ACID REGULATING THE ABCA7 GENE, MOLECULES MODULATING ITS ACTIVITY AND THERAPEUTIC APPLICATIONS
EP1334186A2 (en) * 2000-10-24 2003-08-13 Aventis Pharma S.A. Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications
AUPR107800A0 (en) * 2000-10-27 2000-11-23 University Of Sydney, The Peptide and nucleic acid molecule ii
MXPA03003745A (en) * 2000-10-30 2003-10-15 Bristol Myers Squibb Co Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme.
WO2002036781A2 (en) * 2000-10-31 2002-05-10 Bayer Aktiengesellschaft Regulation of human glutathione-s-transferase
WO2002048369A2 (en) * 2000-11-02 2002-06-20 Bristol-Myers Squibb Company Polynucleotide encoding a human potassium channel beta-subunit, k+mbeta1
AU2002225852A1 (en) * 2000-11-14 2002-05-27 Millenium Pharmaceuticals, Inc. "67118", "67067" and "62092", human proteins and methods of use thereof
US20040053835A1 (en) * 2000-11-17 2004-03-18 Sophia Kossida Regulation of human nmda receptor
WO2002042457A1 (en) 2000-11-22 2002-05-30 Bristol-Myers Squibb Company Cloning and expression of human slap-2: a novel sh2/sh3 domain-containing human slap homologue having immune cell-specific expression
CA2324663A1 (en) * 2000-11-27 2002-05-27 The Hospital For Sick Children A novel adapter gene
WO2002044358A2 (en) * 2000-11-28 2002-06-06 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosis and treatment of cancer using arginine m ethyltransferase 3
WO2002081667A2 (en) * 2000-12-05 2002-10-17 Incyte Genomics, Inc. Ligases
AU2002235748A1 (en) * 2000-12-05 2002-06-18 Bayer Aktiengesellschaft Regulation of human patched-like protein
WO2002046767A2 (en) * 2000-12-08 2002-06-13 Oxford Glycosciences (Uk) Ltd. Diagnosis and treatment of alzheimer's disease
US20040082051A1 (en) * 2000-12-14 2004-04-29 Zhimin Zhu Regulation of human uridine kinase
US7122345B2 (en) 2001-01-09 2006-10-17 Curagen Corporation Nucleic acid encoding a NOVX13 polypeptide
CA2433740A1 (en) * 2001-01-09 2002-07-18 Keio University Human glioma antigen and process for preparing the same
WO2002055707A2 (en) * 2001-01-10 2002-07-18 Rigel Pharmaceuticals Inc Cloning of an inhibitor of antigen-receptor signaling by a retroviral-based functional screen
US6605710B2 (en) * 2001-01-11 2003-08-12 Board Of Trustees Of Michigan State University Gene whose expression promotes differentiation of myeloid progenitor cells into neutrophils and/or monocytes/macrophages
US20020119523A1 (en) * 2001-01-17 2002-08-29 Millennium Pharmaceuticals, Inc. 67073, a human phospholipid transporter family member and uses therefor
US7317085B2 (en) * 2001-01-22 2008-01-08 Shinae Kondoh Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby
EP1432801A2 (en) * 2001-02-06 2004-06-30 Incyte Genomics, Inc. Receptors and membrane-associated proteins
EP1383797A2 (en) * 2001-02-07 2004-01-28 Universiteit Maastricht Markers of unstable atherosclerotic plaques
WO2002064783A2 (en) * 2001-02-09 2002-08-22 Lion Bioscience Ag Novel cofactors of the estrogen receptor beta and methods of use
AU2002250911A1 (en) * 2001-02-12 2002-08-28 Bayer Aktiengesellschaft Isolated polynucleotides encoding putative tyrosine kinase
WO2002064777A2 (en) * 2001-02-14 2002-08-22 Axaron Bioscience Ag Proteins 7b6 and 11b4 and dna sequences encoding the same
GB0104440D0 (en) * 2001-02-22 2001-04-11 Oxford Biomedica Ltd Novel genes
EP1373526A4 (en) * 2001-03-08 2006-01-25 Curagen Corp Therapeutic polypeptides, nucleic acids encoding same, and methodes of use
WO2002072138A1 (en) * 2001-03-08 2002-09-19 Hyseq, Inc. Methods and materials relating to fibulin-like polypeptides and polynucleotides
AU2002250143A1 (en) * 2001-03-16 2002-10-03 Eli Lilly And Company Lp mammalian proteins; related reagents
US20020168668A1 (en) * 2001-03-27 2002-11-14 Millennium Pharmaceuticals, Inc. 14691, a human glutamate receptor family member and uses therefor
US6913904B2 (en) * 2001-03-27 2005-07-05 Applera Corporation Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
AU2002309513A1 (en) * 2001-03-27 2002-10-08 Human Genome Sciences, Inc. Human secreted proteins
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
JP2005507236A (en) * 2001-04-03 2005-03-17 キュラジェン コーポレイション Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding antigens, and methods of use
EP1573024A4 (en) 2001-04-10 2007-08-29 Agensys Inc Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
WO2002083919A2 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
US6607895B2 (en) 2001-04-16 2003-08-19 Lexicon Genetics Incorporated Human adenylsuccinate synthetase and polynucleotides encoding the same
US7309760B2 (en) * 2001-04-17 2007-12-18 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions
WO2002083866A2 (en) * 2001-04-17 2002-10-24 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
WO2002085922A2 (en) * 2001-04-23 2002-10-31 Curagen Corporation Proteins and nucleic acids encoding same
CA2445532A1 (en) * 2001-04-27 2002-11-07 Sunnybrook & Women's College Health Sciences Centre Breast cancer-associated genes and uses thereof
AUPR470101A0 (en) * 2001-05-02 2001-05-24 Murdoch Childrens Research Institute, The A molecular marker
US20030017159A1 (en) * 2001-05-02 2003-01-23 Jerome Ritz Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof
EP1403368B1 (en) 2001-05-29 2010-09-01 Human Cell Systems, Inc. Testicular carnitine transporter and its gene
AU2002327176A1 (en) * 2001-06-06 2002-12-16 Human Genome Sciences, Inc. 20 human secreted proteins
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7235358B2 (en) * 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
EG26529A (en) 2001-06-11 2014-01-27 مونسانتو تكنولوجى ل ل سى Cotton event mon 15985 and compositions and methods for detection thereof
EP1407049A4 (en) * 2001-06-19 2005-03-23 David Gladstone Inst Histone deacetylase and methods of use thereof
AU2002302851A1 (en) * 2001-06-21 2003-01-08 Isis Innovations Limited Atopy
AT410945B (en) * 2001-06-27 2003-08-25 Burkhard Dr Jansen Diagnosis of multiple sclerosis or tumors, by detecting absence of wild-type stem cell factor-apoptosis response gene, or the derived protein, also new nucleic acids
US20030120040A1 (en) 2001-06-29 2003-06-26 Genentech, Inc. Secreted and Transmembrane polypeptides and nucleic acids encoding the same
CA2451374A1 (en) * 2001-07-05 2003-01-16 Wyeth Aggrecanase molecules
JP4702819B2 (en) * 2001-08-01 2011-06-15 生化学工業株式会社 Chondroitin synthase
GB2399087A (en) * 2001-08-02 2004-09-08 Aeomica Inc Human zinc finger containing gene MDZ7
EP1423426A1 (en) * 2001-08-15 2004-06-02 Endocube SAS Sut-2 and sut-3 genes, proteins and assays for inhibitors of lymphocyte adhesion
JP4265402B2 (en) 2001-09-25 2009-05-20 ソニー株式会社 Composition for inhibiting transcription comprising p300 histone acetylase inhibitor and method for screening for inhibitor capable of inhibiting p300 histone acetylase inhibitor
WO2003031627A1 (en) * 2001-09-28 2003-04-17 Hokkaido Technology Licensing Office Co., Ltd. Platelet-origin polypeptides having sphingosine kinase activity and sphingosine kinase genes encoding the same
DE10148037A1 (en) * 2001-09-28 2003-04-17 Aventis Behring Gmbh Use of the protease activating the blood coagulation factor VII for the prophylaxis and therapy of vaso-proliferative diseases
US7138370B2 (en) * 2001-10-11 2006-11-21 Amgen Inc. Specific binding agents of human angiopoietin-2
CA2463000A1 (en) * 2001-10-26 2003-08-07 Incyte Genomics, Inc. Vesicle-associated proteins
JPWO2003037930A1 (en) * 2001-10-29 2005-02-17 財団法人かずさディー・エヌ・エー研究所 Novel human N-methyl-D-aspartate (NMDA) glutamate receptor polypeptide and gene encoding the same
WO2003038040A2 (en) * 2001-10-29 2003-05-08 Millennium Pharmaceuticals, Inc. 32235, a human aminotransferase family member and uses therefor
GB2381526A (en) * 2001-11-03 2003-05-07 Sequenom Inc Detection of predisposition to osteoporosis
ATE553120T1 (en) 2001-11-16 2012-04-15 Eisai R&D Man Co Ltd PROTEINS OF THE JEAP FAMILY, COMPONENTS OF THE TIGHT CONNECTIONS OF THE EXOCRINE GLANDS
EP2186820B1 (en) 2001-11-26 2016-06-08 Laboratoire Biodim Protein-protein interactions in human immunodeficiency virus
AUPR913901A0 (en) * 2001-11-27 2001-12-20 Children's Medical Research Institute Muscle transcription factors
AU2002365894A1 (en) * 2001-11-30 2003-06-17 Children's Hospital Medical Center Antibodies to magmas and uses thereof
ATE451387T1 (en) * 2001-12-18 2009-12-15 Endocube Sas NEW CELL DEATH-ASSOCIATED PROTEINS FROM THE THAP FAMILY AND PAR4-RELATED SIGNALING PATHWAYS INVOLVED IN THE CONTROL OF APOPTOSIS
US7858297B2 (en) 2001-12-18 2010-12-28 Centre National De La Recherche Scientifique Cnrs Chemokine-binding protein and methods of use
WO2003064654A1 (en) * 2002-02-01 2003-08-07 Bayer Healthcare Ag Human serine/threonine protein kinase
JP2003252801A (en) * 2002-02-27 2003-09-10 Japan Science & Technology Corp Method for using pituitary-specific gene
WO2003079884A2 (en) 2002-03-19 2003-10-02 Children's Medical Center Corporation Methods for diagnosis and prognosis of cancer
AU2003220274A1 (en) * 2002-03-22 2003-10-13 Munin Corporation Cloning and characterization of g+c-rich promoter binding protein
US7473526B2 (en) * 2002-03-29 2009-01-06 Veridex, Llc Breast cancer prognostic portfolio
AU2003240572A1 (en) * 2002-05-30 2003-12-19 Avalon Pharmaceuticals, Inc. Cancer-linked gene as target for chemotherapy
AU2003260618A1 (en) * 2002-06-24 2004-01-06 Exonhit Therapeutics Sa Treatment of amyotrophic lateral sclerosis using pgc-1 activity-modulating compounds
GB0215406D0 (en) * 2002-07-03 2002-08-14 Inpharmatica Ltd Protein
US7122358B2 (en) 2002-07-09 2006-10-17 Bristol-Myers Squibb Company Testis-specific tubulin tyrosine-ligase-like protein, BGS42
AU2003249013A1 (en) 2002-07-09 2004-01-23 Bristol-Myers Squibb Company Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, bgs42
WO2004031388A1 (en) * 2002-07-25 2004-04-15 Sony Corporation Factor participating in transcriptional regulation
WO2004012817A2 (en) * 2002-07-31 2004-02-12 Kylix B.V. Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
DE10309368A1 (en) * 2002-08-06 2004-02-26 Aventis Behring Gmbh Intellectual Property/Legal Pharmaceutical preparation with RNA as a cofactor of hemostasis
WO2004015108A1 (en) * 2002-08-09 2004-02-19 Melbourne Health Mammalian grainyhead transcription factors
WO2004016733A2 (en) 2002-08-16 2004-02-26 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
AU2003267097B2 (en) * 2002-09-11 2009-09-17 Genentech, Inc. Novel composition and methods for the treatment of psoriasis
GB2409680B (en) * 2002-10-02 2006-09-20 Us Gov Health & Human Serv Methods and medicaments for controlling proliferation of cells
WO2004037858A2 (en) * 2002-10-25 2004-05-06 Technische Universitaet Muenchen Nipa, a nuclear interacting partner of anaplastic lymphoma kinase, polypeptides and use thereof
JP2006516189A (en) * 2002-11-15 2006-06-29 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー CA125 gene and its use for diagnosis and therapy
DE10254601A1 (en) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Gene products differentially expressed in tumors and their use
GB0228337D0 (en) * 2002-12-05 2003-01-08 Yorkshire Cancer Res Campaign Replication protein
WO2004053077A2 (en) * 2002-12-05 2004-06-24 Diadexus, Inc. Compositions,splice variants and methods relating to breast specific genes and proteins
EP1576005A2 (en) * 2002-12-27 2005-09-21 Applied Research Systems ARS Holding N.V. Notch-like polypeptides
US7326768B2 (en) 2003-02-05 2008-02-05 Juan Saus Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
WO2004085648A2 (en) 2003-03-19 2004-10-07 Biogen Idec Ma Inc. Nogo receptor binding protein
JP4643450B2 (en) 2003-08-08 2011-03-02 株式会社ペルセウスプロテオミクス Cancer high expression gene
WO2005023833A2 (en) * 2003-09-05 2005-03-17 Cellzome Ag Treatment of neurodegenerative diseases
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
CN102895663A (en) 2004-04-14 2013-01-30 健泰科生物技术公司 Compositions containing EGFL 7 antagonist for modulating vascular development and methods
DE102004024617A1 (en) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use
CA2619256A1 (en) * 2004-09-24 2006-03-30 Mount Sinai Hospital Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnover
GB0426960D0 (en) 2004-12-08 2005-01-12 Ares Trading Sa TGR-3 like protein receptor
US8258258B2 (en) 2005-03-10 2012-09-04 Biontech Ag Dimeric or multimeric microproteins
WO2007008732A2 (en) 2005-07-07 2007-01-18 Yale University Compositions and methods for suppressing axonal growth inhibition
SG163591A1 (en) 2005-07-08 2010-08-30 Biogen Idec Inc Sp35 antibodies and uses thereof
EP1790664A1 (en) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
US7811787B2 (en) 2006-04-25 2010-10-12 Bristol-Myers Squibb Company Polynucleotides encoding human SLAP-2 variant, hSLAP-2v3
US8128926B2 (en) 2007-01-09 2012-03-06 Biogen Idec Ma Inc. Sp35 antibodies and uses thereof
DK2982695T3 (en) 2008-07-09 2019-05-13 Biogen Ma Inc COMPOSITIONS CONCERNING ANTIBODIES AGAINST LINGO OR FRAGMENTS THEREOF
DE102008045696A1 (en) 2008-09-04 2010-03-11 Drk Blutspendedienst West Ggmbh Granulocyte HNA-3a / b antigen
EP2358748B1 (en) * 2008-12-09 2016-07-06 Dana-Farber Cancer Institute, Inc. Methods and compositions for specific modulation of mcl-1
SG174367A1 (en) 2009-03-23 2011-10-28 Quark Pharmaceuticals Inc Compounds compositions and methods of treating cancer and fibrotic diseases
PE20120902A1 (en) 2009-05-08 2012-08-08 Genentech Inc HUMANIZED ANTI-EGFL7 ANTIBODIES
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
WO2013173364A2 (en) 2012-05-14 2013-11-21 Biogen Idec Ma Inc. Lingo-2 antagonists for treatment of conditions involving motor neurons
WO2013174404A1 (en) 2012-05-23 2013-11-28 Ganymed Pharmaceuticals Ag Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
MX369276B (en) 2012-11-13 2019-11-04 Biontech Ag Agents for treatment of claudin expressing cancer diseases.
WO2014127785A1 (en) 2013-02-20 2014-08-28 Ganymed Pharmaceuticals Ag Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
WO2014146672A1 (en) 2013-03-18 2014-09-25 Ganymed Pharmaceuticals Ag Therapy involving antibodies against claudin 18.2 for treatment of cancer
US20160304584A1 (en) * 2013-12-03 2016-10-20 INSERM (Institut National de la Santé et de la Recherche Médicale Mafb mutants and uses thereof
WO2016112270A1 (en) 2015-01-08 2016-07-14 Biogen Ma Inc. Lingo-1 antagonists and uses for treatment of demyelinating disorders
CN112190710B (en) * 2020-10-28 2021-07-30 江苏省人民医院（南京医科大学第一附属医院） Application of lipid-derived polypeptide in preparation of metastatic breast cancer targeted drug
WO2022212928A1 (en) * 2021-04-02 2022-10-06 The Regents Of The University Of California Modified viruses and viral particles, methods of making, and uses thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU783485B2 (en) * 1999-11-10 2005-11-03 Lexicon Pharmaceuticals, Inc. Human atpase proteins and polynucleotides encoding the same
AU784349B2 (en) * 2000-01-12 2006-03-16 Yale University Nogo receptor-mediated blockade of axonal growth
AU784349C (en) * 2000-01-12 2006-09-28 Yale University Nogo receptor-mediated blockade of axonal growth
AU2001249421B2 (en) * 2000-03-24 2006-09-07 Genetics Institute, Llc A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor
AU2001262734B2 (en) * 2000-06-14 2004-09-30 Sankyo Company, Limited Ceramide kinase and DNA encoding the same

Also Published As

Publication number Publication date
EP1165784A2 (en) 2002-01-02
JP2004507202A (en) 2004-03-11
WO2000058473A3 (en) 2001-01-25
CA2383592A1 (en) 2000-10-05
WO2000058473A2 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
AU3774500A (en) Nucleic acids including open reading frames encoding polypeptides; "orfx"
AU1220001A (en) Novel proteins and polynucleotides encoding them
AU6311798A (en) MRI contrast media recognizing microenvironmental changes
AU1675900A (en) Complementary dna's encoding proteins with signal peptides
AU5372399A (en) Dna encoding a human inhibitor-of-apoptosis protein; hiap3
AU4930399A (en) Novel Polypeptide
AU1891301A (en) Novel polypeptide and dna thereof
AU2071799A (en) Placental protein 13
AU2691500A (en) Novel polypeptide
HK1048495A1 (en) Dna encoding prost 07 polypeptide
GB9903430D0 (en) Novel proteins
AU4778600A (en) Novel polypeptide
AU3452700A (en) Antibodies to placental protein 13
AU1453601A (en) Novel polypeptides and nucleic acids encoding same
AU4306401A (en) Dna encoding a novel prost-ets polypeptide
AU1486801A (en) Novel growth factor polypeptides and nucleic acids encoding same
AU1458600A (en) Transmembrane 4 proteins
AU1540701A (en) Novel protein
AU6181500A (en) Gene encoding novel tsp1-like protein
AU5840300A (en) Glutx polypeptide family and nucleic acids encoding same
AU1184800A (en) Novel polypeptide
AU2057800A (en) Novel hyaluronan-binding proteins and encoding genes
AU2002500A (en) Novel protein
AU7304600A (en) Novel protein
AU2109200A (en) Polypeptide